In the case of NAFLD, ROS regulate the activation of the NF‐κB pathway by upregulating the expression of the proinflammatory cytokine TNF‐α (Oliveira‐Marques et al., 2009). The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.